Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention

Breast Cancer Research and Treatment

Volumn 158, Issue 1, 2016, Pages 29-41

  Colacino, Justin A ^a,b   McDermott, Sean P ^b   Sartor, Maureen A ^b,c   Wicha, Max S ^b   Rozek, Laura S ^a,b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Breast stem cell; Curcumin; Prevention; RNA seq; Stearoyl coa desaturase

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; CURCUMIN; HERMES ANTIGEN; PALMITOLEIC ACID; PIPERINE; SMALL INTERFERING RNA; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; ANTINEOPLASTIC AGENT; PIPERIDINE DERIVATIVE; SCD1 PROTEIN, HUMAN;

ALDH1A3 GENE; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER PREVENTION; CANCER STEM CELL; CD49F GENE; CELL SELF-RENEWAL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MCF10A CELL LINE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROM1 GENE; RNA SEQUENCE; TP63 GENE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; BREAST TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; MCF-7 CELL LINE; METABOLISM; PROCEDURES; SEQUENCE ANALYSIS; STEM CELL; TUMOR CELL LINE;

ALKALOIDS; ANTINEOPLASTIC AGENTS; BENZODIOXOLES; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CURCUMIN; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; SEQUENCE ANALYSIS, RNA; STEAROYL-COA DESATURASE; STEM CELLS;

EID: 84974808034     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3854-4     Document Type: Article

References (48)

1. Jemal A et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277–300
2. Brandberg Y et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949
3. Fisher B et al (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388
4. Vogel VG et al (2010) Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 Trial: preventing breast cancer. Cancer Prev Res (Phila) 3(6):696–706
5. Howell A (2008) The endocrine prevention of breast cancer. Best Pract Res Clin Endocrinol Metab 22(4):615–623
6. Noorafshan A, Ashkani-Esfahani S (2013) A review of therapeutic effects of curcumin. Curr Pharm Des 19(11):2032–2046
7. Shoba G et al (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64(4):353–356
8. Dontu G et al (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10):1253–1270
9. Kakarala M et al (2010) Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122(3):777–785
10. Molyneux G et al (2010) BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7(3):403–417
11. Al-Hajj M et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983–3988
12. Van Keymeulen A et al (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479(7372):189–193
13. Liu S et al (2013) Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2(1):78–91
14. Dobin A et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15–21
15. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140
16. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological), p 289–300
17. Lim E et al (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15(8):907–913
18. Svedberg J et al (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39(5):570–574
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408
20. R Core Team R: A language and environment for statistical computing. 2013: R Foundation for Statistical Computing, Vienna, Austria
21. Eirew P et al (2012) Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells. Stem Cells 30(2):344–348
22. Keller PJ et al (2012) Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA 109(8):2772–2777
23. Isfoss BL et al (2013) Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules. BMC Clin Pathol 13(1):28
24. Kunju LP et al (2011) EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod Pathol 24(6):786–793
25. Zhong Y et al (2013) Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse. Cancer Cell Int 13(1):60
26. Sheridan C et al (2006) CD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8(5):R59
27. Mani SA et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704–715
28. Yang C et al (2009) Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282:133–141
29. McNally SJ et al (2007) Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med 19(1):165–172
30. Motterlini R et al (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med 28(8):1303–1312
31. Shen SQ et al (2007) Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13(13):1953–1961
32. Dunsmore KE, Chen PG, Wong HR (2001) Curcumin, a medicinal herbal compound capable of inducing the heat shock response. Crit Care Med 29(11):2199–2204
33. Newman B et al (2012) HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells. Cancer Res 72(17):4551–4561
34. Lee CH et al (2012) Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie 94(6):1382–1389
35. Subramaniam D et al (2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 7(2):e30590
36. Charpentier MS et al (2014) Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res 74(4):1250–1260
37. Whipple RA et al (2008) Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells. Cancer Res 68(14):5678–5688
38. Bhardwaj RK et al (2002) Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302(2):645–650
39. Duangjai A et al (2013) Black pepper and piperine reduce cholesterol uptake and enhance translocation of cholesterol transporter proteins. J Nat Med 67(2):303–310
40. Hong J et al (2004) Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25(9):1671–1679
41. Lev-Ari S et al (2006) Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. J Soc Integr Oncol 4(1):21–26
42. Kudo C et al (2011) Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res 31(11):3719–3726
43. Shin HS et al (2014) Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice. J Ethnopharmacol 153(1):142–150
44. Igal RA (2010) Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 31(9):1509–1515
45. Noto A et al (2013) Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells. Cell Death Dis 4:e947
46. Mauvoisin D et al (2013) Decreasing stearoyl-CoA desaturase-1 expression inhibits beta-catenin signaling in breast cancer cells. Cancer Sci 104(1):36–42
47. Rios-Esteves J, Marilyn Resh D (2013) Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. Cell Rep 4(6):1072–1081
48. Coleman DT et al (2015) Curcumin prevents palmitoylation of integrin beta4 in breast cancer cells. PLoS One 10(5):e0125399